Global Alpha Galactosidase Market Insights, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 113

Report ID: 19165

Alpha-galactosidase (α-GAL) is a glycoside hydrolase enzyme that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. It is the primary ingredient in gas relief supplements. Glycosidase is an important class of enzyme catalyzing many catabolic processes, including cleaving glycoproteins and glycolipids, and polysaccharides.
The global Alpha Galactosidase market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alpha Galactosidase market based on company, product type, end user and key regions.

This report studies the global market size of Alpha Galactosidase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alpha Galactosidase in these regions.
This research report categorizes the global Alpha Galactosidase market by top players/brands, region, type and end user. This report also studies the global Alpha Galactosidase market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
JCR Pharmaceuticals
Bestochem
ISU ABXIS
Pharming Group
Protalix Biotherapeutics
Aumgene Biosciences

Alpha Galactosidase market size by Type
Capsule
Tablet
Other
Alpha Galactosidase market size by Applications
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Alpha Galactosidase market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alpha Galactosidase market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alpha Galactosidase companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alpha Galactosidase submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Alpha Galactosidase are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alpha Galactosidase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Alpha Galactosidase Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Alpha Galactosidase Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.4.4 Other
1.5 Market by Application
1.5.1 Global Alpha Galactosidase Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Alpha Galactosidase Market Size
2.1.1 Global Alpha Galactosidase Revenue 2014-2025
2.1.2 Global Alpha Galactosidase Sales 2014-2025
2.2 Alpha Galactosidase Growth Rate by Regions
2.2.1 Global Alpha Galactosidase Sales by Regions
2.2.2 Global Alpha Galactosidase Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Alpha Galactosidase Sales by Manufacturers
3.1.1 Alpha Galactosidase Sales by Manufacturers
3.1.2 Alpha Galactosidase Sales Market Share by Manufacturers
3.2 Alpha Galactosidase Revenue by Manufacturers
3.2.1 Alpha Galactosidase Revenue by Manufacturers (2014-2019)
3.2.2 Alpha Galactosidase Revenue Share by Manufacturers (2014-2019)
3.3 Alpha Galactosidase Price by Manufacturers
3.4 Alpha Galactosidase Manufacturing Base Distribution, Product Types
3.4.1 Alpha Galactosidase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha Galactosidase Product Type
3.4.3 Date of International Manufacturers Enter into Alpha Galactosidase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Alpha Galactosidase Sales by Type
4.2 Global Alpha Galactosidase Revenue by Type
4.3 Alpha Galactosidase Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Alpha Galactosidase Breakdown Data by Application

6 North America
6.1 North America Alpha Galactosidase by Country
6.1.1 North America Alpha Galactosidase Sales by Country
6.1.2 North America Alpha Galactosidase Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Alpha Galactosidase by Type
6.3 North America Alpha Galactosidase by Application

7 Europe
7.1 Europe Alpha Galactosidase by Country
7.1.1 Europe Alpha Galactosidase Sales by Country
7.1.2 Europe Alpha Galactosidase Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alpha Galactosidase by Type
7.3 Europe Alpha Galactosidase by Application

8 Asia Pacific
8.1 Asia Pacific Alpha Galactosidase by Country
8.1.1 Asia Pacific Alpha Galactosidase Sales by Country
8.1.2 Asia Pacific Alpha Galactosidase Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Alpha Galactosidase by Type
8.3 Asia Pacific Alpha Galactosidase by Application

9 Central & South America
9.1 Central & South America Alpha Galactosidase by Country
9.1.1 Central & South America Alpha Galactosidase Sales by Country
9.1.2 Central & South America Alpha Galactosidase Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Alpha Galactosidase by Type
9.3 Central & South America Alpha Galactosidase by Application

10 Middle East and Africa
10.1 Middle East and Africa Alpha Galactosidase by Country
10.1.1 Middle East and Africa Alpha Galactosidase Sales by Country
10.1.2 Middle East and Africa Alpha Galactosidase Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Alpha Galactosidase by Type
10.3 Middle East and Africa Alpha Galactosidase by Application

11 Company Profiles
11.1 JCR Pharmaceuticals
11.1.1 JCR Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 JCR Pharmaceuticals Alpha Galactosidase Sales, Revenue and Gross Margin (2014-2019)
11.1.4 JCR Pharmaceuticals Alpha Galactosidase Products Offered
11.1.5 JCR Pharmaceuticals Recent Development
11.2 Bestochem
11.2.1 Bestochem Company Details
11.2.2 Company Business Overview
11.2.3 Bestochem Alpha Galactosidase Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bestochem Alpha Galactosidase Products Offered
11.2.5 Bestochem Recent Development
11.3 ISU ABXIS
11.3.1 ISU ABXIS Company Details
11.3.2 Company Business Overview
11.3.3 ISU ABXIS Alpha Galactosidase Sales, Revenue and Gross Margin (2014-2019)
11.3.4 ISU ABXIS Alpha Galactosidase Products Offered
11.3.5 ISU ABXIS Recent Development
11.4 Pharming Group
11.4.1 Pharming Group Company Details
11.4.2 Company Business Overview
11.4.3 Pharming Group Alpha Galactosidase Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pharming Group Alpha Galactosidase Products Offered
11.4.5 Pharming Group Recent Development
11.5 Protalix Biotherapeutics
11.5.1 Protalix Biotherapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Protalix Biotherapeutics Alpha Galactosidase Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Protalix Biotherapeutics Alpha Galactosidase Products Offered
11.5.5 Protalix Biotherapeutics Recent Development
11.6 Aumgene Biosciences
11.6.1 Aumgene Biosciences Company Details
11.6.2 Company Business Overview
11.6.3 Aumgene Biosciences Alpha Galactosidase Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Aumgene Biosciences Alpha Galactosidase Products Offered
11.6.5 Aumgene Biosciences Recent Development

12 Future Forecast
12.1 Alpha Galactosidase Market Forecast by Regions
12.1.1 Global Alpha Galactosidase Sales Forecast by Regions 2019-2025
12.1.2 Global Alpha Galactosidase Revenue Forecast by Regions 2019-2025
12.2 Alpha Galactosidase Market Forecast by Type
12.2.1 Global Alpha Galactosidase Sales Forecast by Type 2019-2025
12.2.2 Global Alpha Galactosidase Revenue Forecast by Type 2019-2025
12.3 Alpha Galactosidase Market Forecast by Application
12.4 North America Alpha Galactosidase Forecast
12.5 Europe Alpha Galactosidase Forecast
12.6 Asia Pacific Alpha Galactosidase Forecast
12.7 Central & South America Alpha Galactosidase Forecast
12.8 Middle East and Africa Alpha Galactosidase Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha Galactosidase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer